Efficacy of buparvaquone as a therapeutic and clearing agent of Babesia equi of European origin in horses

J. L. Zaugg From the University of Idaho, Caine Veterinary Teaching and Research Center, 1020 E. Homedale Road, Caldwell, ID 83605.

Search for other papers by J. L. Zaugg in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
and
V. M. Lane From the University of Idaho, Caine Veterinary Teaching and Research Center, 1020 E. Homedale Road, Caldwell, ID 83605.

Search for other papers by V. M. Lane in
Current site
Google Scholar
PubMed
Close
 DVM, MS

Click on author name to view affiliation information

Summary

We evaluated the efficacy of buparvaquone in eliminating infection with Babesia equi of European origin in carrier horses and in splenectomized horses with experimentally induced acute infection. When administered at the rate of 5 mg/kg of body weight, iv, 4 times at 48-hour intervals, buparvaquone prompted rapid abatement of parasitemia. However, secondary and tertiary recrudescent parasitemias invariably returned with establishment of the carrier state. Buparvaquone, at the dosage evaluated, had transitory therapeutic efficacy against acute B equi infection in splenectomized horses, but was unable alone to clear carrier infection.

Summary

We evaluated the efficacy of buparvaquone in eliminating infection with Babesia equi of European origin in carrier horses and in splenectomized horses with experimentally induced acute infection. When administered at the rate of 5 mg/kg of body weight, iv, 4 times at 48-hour intervals, buparvaquone prompted rapid abatement of parasitemia. However, secondary and tertiary recrudescent parasitemias invariably returned with establishment of the carrier state. Buparvaquone, at the dosage evaluated, had transitory therapeutic efficacy against acute B equi infection in splenectomized horses, but was unable alone to clear carrier infection.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 49 49 11
PDF Downloads 23 23 6
Advertisement